Literature DB >> 11742939

Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea.

L Cabanes1, B Richaud-Thiriez, Y Fulla, F Heloire, C Vuillemard, S Weber, D Dusser.   

Abstract

STUDY
OBJECTIVES: In dyspneic patients without left ventricular enlargement, it may be difficult to differentiate between obstructive lung disease and diastolic heart failure. Determination of plasma brain natriuretic peptide (BNP) levels, known to increase with ventricular stretch, may be of clinical relevance in this situation. We compared the discriminant power of BNP blood levels and of echocardiography in patients with either chronic obstructive lung disease or diastolic heart failure. PATIENTS: Twenty-six New York Heart Association class III dyspneic patients with normal left ventricular systolic function were enrolled: 17 patients with chronic obstructive lung disease and 9 patients with unequivocal diastolic heart failure.
RESULTS: Echocardiographic data were unable to accurately differentiate between the two groups, whereas BNP levels were significantly and markedly higher in patients with diastolic heart failure when compared to those with obstructive lung disease (224 +/- 240 pg/mL vs 14 +/- 12 pg/mL, p < 0.0001).
CONCLUSIONS: These preliminary results warrant a prospective, large-scale evaluation of the value of BNP assay for determining diastolic dysfunction, a common cause of dyspnea in elderly patients, and differentiating it from other diagnoses such as obstructive lung disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742939     DOI: 10.1378/chest.120.6.2047

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

Review 1.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 2.  Cardiomyopathy: an overview.

Authors:  Randell K Wexler; Terry Elton; Adam Pleister; David Feldman
Journal:  Am Fam Physician       Date:  2009-05-01       Impact factor: 3.292

3.  Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea.

Authors:  Patrick Ray; Martine Arthaud; Yannick Lefort; Sophie Birolleau; Catherine Beigelman; Bruno Riou
Journal:  Intensive Care Med       Date:  2004-10-22       Impact factor: 17.440

4.  Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapy.

Authors:  Jorg Bojunga; Christoph Sarrazin; Georg Hess; Stefan Zeuzem
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

5.  Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure.

Authors:  Angela Beatrice Scardovi; Renata De Maria; Andrea Celestini; Claudio Coletta; Nadia Aspromonte; Silvia Perna; Marina Parolini; Roberto Ricci
Journal:  Intern Emerg Med       Date:  2008-06-17       Impact factor: 3.397

6.  High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia-Martina Ferrari; Fabio Galetta; Ferdinando Franzoni; Gino Santoro; Salvatore De Marco; Emiliano Ghiri; Poupak Fallahi
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

7.  Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Am J Med       Date:  2004-04-15       Impact factor: 4.965

Review 8.  Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology.

Authors:  Nathaniel Mark Hawkins; Mark C Petrie; Pardeep S Jhund; George W Chalmers; Francis G Dunn; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

9.  Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide.

Authors:  Lafayete William F Ramos; Neif Murad; Eduardo Goto; Edinei L Antônio; José A Silva; Paulo F Tucci; Antônio C Carvalho
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037

10.  Impact of blunted perception of dyspnea on medical care use and expenditure, and mortality in elderly people.

Authors:  Satoru Ebihara; Kaijun Niu; Takae Ebihara; Shinichi Kuriyama; Atsushi Hozawa; Kaori Ohmori-Matsuda; Naoki Nakaya; Ryoichi Nagatomi; Hiroyuki Arai; Masahiro Kohzuki; Ichiro Tsuji
Journal:  Front Physiol       Date:  2012-07-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.